On November 7, 2023, the Federal Trade Commission announced that it is challenging more than 100 patents held by 10 branded drug companies as improperly or inaccurately listed in the.
Enacted by Congress in 1984, the Hatch-Waxman Act balances the need for lower-cost prescription drugs and the protection of pharmaceutical innovations. While Hatch-Waxman litigation.
Companies rely on the protections of privilege to obtain sound legal advice to guide their businesses. It is becoming increasingly important to know how to navigate the ins and outs of.